Stockscreener 앱 받기
114.32
1.70%
-1.98
시장 영업 전:
112.31
-2.01
-1.76%
Repligen Corp 주식(RGEN)의 최신 뉴스
E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan
Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan
Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan
Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan
RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus
H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat
Is Repligen (NASDAQ:RGEN) Influenced By Nasdaq Index Volatility? - Kalkine Media
Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance
Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS
Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - AD HOC NEWS
Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance
Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance
270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat
Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com
Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance
Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance
Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st
Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corporation to Present at Upcoming March Conferences - ChartMill
Bioprocessing firm Repligen fields CEO, CFO at three March investor conferences - Stock Titan
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Repligen Corporation $RGEN Shares Sold by TD Asset Management Inc - MarketBeat
NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan
Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan
Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan
Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead - Yahoo Finance
Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews
Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat
Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Primecap Management Co. CA Has $24.98 Million Stock Position in Repligen Corporation $RGEN - MarketBeat
Repligen (NASDAQ:RGEN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - Yahoo Finance
Repligen Corp (RGEN) Shares Down 3.09% on Feb 27 - GuruFocus
Oversold Conditions For Repligen (RGEN) - Nasdaq
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Repligen (NASDAQ: RGEN) maps 2025 bioprocessing market, debt and control risks - Stock Titan
A Glimpse Into The Expert Outlook On Repligen Through 6 Analysts - Benzinga
Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar
Barclays Has Lowered Expectations for Repligen (NASDAQ:RGEN) Stock Price - MarketBeat
Barclays Adjusts Repligen (RGEN) Target Price Amid Overweight Ra - GuruFocus
Wells Fargo Lowers Price Target for RGEN, Maintains Overweight R - GuruFocus
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz
Repligen (NASDAQ:RGEN) Price Target Lowered to $180.00 at Wells Fargo & Company - MarketBeat
Evercore ISI Group Lowers Price Target for Repligen (RGEN) to $1 - GuruFocus
KeyBanc reiterates Repligen stock rating on product momentum - Investing.com
How The Repligen (RGEN) Narrative Is Shifting With New Targets M&A Plans And Products - Yahoo Finance
Repligen (RGEN) Return To Profitability Tests Bullish Growth Narrative In Q4 2025 Results - simplywall.st
Repligen Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
0.95%
0.04%
자본화:
|
볼륨(24시간):